Back to News
investment

Nomura Value Fund Q4 2025 Portfolio Review

Seeking Alpha
Loading...
2 min read
0 likes
⚡ Quantum Brief
Nomura Value Fund underperformed the Russell 1000® Value Index in Q4 2025, with institutional shares trailing the benchmark due to stock selection challenges. The fund exited its position in Kenvue Inc. (KVUE) in October, divesting from the consumer health giant behind brands like Band-Aid, Listerine, and Tylenol. Zoetis remained a key holding, with two-thirds of its revenue derived from companion animal products, while livestock solutions accounted for the remaining third. Macquarie Asset Management, the fund’s adviser, operates as an integrated asset manager across public and private markets, including equities, credit, and real assets. The commentary highlighted portfolio adjustments but provided no specific details on new acquisitions or sector shifts during the quarter.
AI Audio Summary
0:00 / 0:00
Click to play
dcbb6659-0daf-4a2e-923f-3b6f2f91cf21.jpeg
Quantum News · Media Library

Macquarie Asset Management31 FollowersFollow5ShareSaveCommentsSummaryFor 4Q2025, Nomura Value Fund institutional Class shares modestly trailed its benchmark, the Russell 1000® Value Index.In October, we sold our position in Kenvue Inc. (KVUE), a consumer health company with globally recognizable brands such as Band-Aid, Listerine, Neutrogena, Tylenol, and Johnson's baby products.Approximately two-thirds of Zoetis's revenue is generated by products for companion animals while the remainder comes from products for livestock. ARMMY PICCA/iStock via Getty Images The following segment was excerpted from the Nomura Value Fund Q4 2025 Commentary. Within the Fund For 4Q2025, Nomura Value Fund institutional Class shares modestly trailed its benchmark, the Russell 1000® Value Index. At the portfolio level, stock selectionThis article was written byMacquarie Asset Management31 FollowersFollowMacquarie Asset Management (MAM) is the asset management division of Macquarie Group. MAM is an integrated asset manager across public and private markets offering a diverse range of capabilities, including real assets, real estate, credit, equities and multi-asset solutions. Macquarie Group refers to Macquarie Group Limited and its subsidiaries and affiliates worldwide. Delaware Funds by Macquarie refers to certain investment solutions that MAM distributes, offers, or advises. Investment advisory services are provided to the Delaware Funds by Delaware Management Company, a series of Macquarie Investment Management Business Trust (MIMBT), a Securities and Exchange Commission (SEC) registered investment adviser.

The Delaware Funds are distributed by Delaware Distributors, L.P., a registered broker/dealer and member of the Financial Industry Regulatory Authority (FINRA) and an affiliate of MIMBT. Note: This account is not managed or monitored by Macquarie Asset Management, and any messages sent via Seeking Alpha will not receive a response. For inquiries or communication, please use the Macquarie Asset Management's official channels.

Read Original

Source Information

Source: Seeking Alpha

Discussion

0 professional contributions

Sign in to join this professional discussion.

Be the first to add a constructive contribution.